Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Oleo Sci ; 69(9): 1087-1093, 2020 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-32788522

RESUMEN

Previously, we reported that the polar lipid fraction from the golden oyster mushroom, Pleurotus citrinopileatus, suppresses colon injuries which result from apoptosis induced by inflammatory stresses in vivo and in vitro (Yamashita et al., J. Oleo Sci., 69, 751-757 (2020)). Here, we investigated the use of lipid classes in mushroom polar lipid fraction in alleviating colon injury using differentiated Caco-2 cells as an intestinal tract model. The mushroom polar lipid fraction was separated into four fractions using silica thin layer chromatography. Each mushroom polar lipid fraction suppressed lipopolysaccharide (LPS)-induced decreases in the viability of intestinal cells, and the effects of sphingolipid fractions were significantly stronger than those of fraction that did not contain sphingolipids. Addition of sphingolipid fractions suppressed the expression of apoptosis-related proteins (e.g., death receptors and caspases) in the LPS-treated cells. Mushroom polar lipids, especially sphingolipids suppress intestinal apoptosis induced by inflammatory stress, and highly polar sphingolipids may exert stronger suppressive effects.


Asunto(s)
Apoptosis/efectos de los fármacos , Enfermedades del Colon/tratamiento farmacológico , Enfermedades del Colon/patología , Fitoterapia , Pleurotus/química , Esfingolípidos/aislamiento & purificación , Esfingolípidos/farmacología , Apoptosis/genética , Células CACO-2 , Caspasas/genética , Caspasas/metabolismo , Fraccionamiento Químico , Enfermedades del Colon/inducido químicamente , Expresión Génica , Humanos , Técnicas In Vitro , Inflamación , Lipopolisacáridos , Esfingolípidos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA